Globus Medical, Inc.
GMED
$91.04
-$0.04-0.04%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 423.78M | 356.65M | 185.56M | 102.98M | 91.51M |
| Total Depreciation and Amortization | 276.25M | 272.19M | 265.31M | 254.57M | 257.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.19M | 25.23M | 239.92M | 260.64M | 236.18M |
| Change in Net Operating Assets | -18.02M | 15.09M | -45.24M | -97.55M | -170.22M |
| Cash from Operations | 715.20M | 669.16M | 645.55M | 520.64M | 414.97M |
| Capital Expenditure | -135.59M | -141.73M | -122.96M | -115.43M | -121.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -252.55M | -252.65M | -4.99M | -17.64M | -17.64M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.45M | 107.56M | 129.87M | -42.99M | 387.52M |
| Cash from Investing | -347.69M | -286.81M | 1.92M | -176.05M | 248.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -449.99M | -449.99M | -449.99M | -- | -- |
| Issuance of Common Stock | 96.28M | 108.71M | 118.25M | 110.44M | 42.20M |
| Repurchase of Common Stock | -259.08M | -220.18M | -196.60M | -92.52M | -327.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.86M | -19.56M | -19.03M | -45.62M | -39.13M |
| Cash from Financing | -632.64M | -581.02M | -547.37M | -27.70M | -324.70M |
| Foreign Exchange rate Adjustments | 14.13M | 17.69M | 7.11M | 255.00K | 4.19M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -251.00M | -180.98M | 107.20M | 317.15M | 343.15M |